Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of recombinant acellular pertussis-containing vaccines in healthy women of childbearing age
TCTR20180321004Phase 2Completed
- Sponsor
- BioNet
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 2 trial in pertussis, sponsored by BioNet. Started Jul 2018; status: completed.
02
Conditions
pertussis
Beyond the preview
Go deeper on TCTR20180321004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180321004.